EARLY ALZHEIMER'S DISEASE
Clinical trials for EARLY ALZHEIMER'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new EARLY ALZHEIMER'S DISEASE trials appear
Sign up with your email to follow new studies for EARLY ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major Alzheimer's drug trial aims to slow memory loss
Disease control OngoingThis large, late-stage study is testing whether the drug lecanemab can slow the progression of early Alzheimer's disease. Nearly 2,000 participants with mild memory problems will receive either the drug or a placebo for 18 months, followed by an optional long-term extension phase…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE3 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
New pill aims to protect the brain in Alzheimer's
Disease control OngoingThis study is testing whether a new daily pill called CT1812 can slow the progression of early Alzheimer's disease. About 540 people with early memory problems will take either the drug or a placebo for 18 months. Researchers will measure changes in memory, thinking skills, and d…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Cognition Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Diabetes drug could be key to slowing Alzheimer's progression
Disease control OngoingThis large, late-stage trial is investigating whether a pill called semaglutide, already used for diabetes, can slow the progression of early Alzheimer's disease. About 1,840 participants with mild memory problems will be randomly assigned to receive either the real medication or…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Two-Year brain drug trial seeks to slow Alzheimer's decline
Disease control OngoingThis study is testing the long-term safety and effectiveness of the drug ALZ-801 in people with early Alzheimer's disease who have a specific genetic makeup (APOE4/4). It follows 163 participants for two years to see if the drug can help slow the decline in memory and thinking sk…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE3 • Sponsor: Alzheon Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Diabetes drug could be key to slowing Alzheimer's, major trial underway
Disease control OngoingThis large, late-stage trial is testing whether a pill called semaglutide, already used for diabetes, can slow the progression of early Alzheimer's disease. About 1,840 participants with mild memory problems will take either the real medicine or a placebo pill for over three year…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC